Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson

BACKGROUND: Immune checkpoint inhibitors (ICPIs) are gaining increasing popularity as an efficacious treatment for advanced malignancies. ICPI treatment can be complicated by diarrhea and colitis. Systemic steroids are the first line treatment. Infliximab is reserved for severe refractory cases. We...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Wang, Yinghong, Abu-Sbeih, Hamzah, Mao, Emily, Ali, Noman, Ali, Faisal Shaukat, Qiao, Wei, Lum, Phillip, Raju, Gottumukkala, Shuttlesworth, Gladis, Stroehlein, John, Diab, Adi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5946546/
https://ncbi.nlm.nih.gov/pubmed/29747688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0346-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados